Target intelligence / Profile preview

Dorsal column of the spinal cord

Molecular classification
Other
01

Overview

The dorsal column of the spinal cord is a major ascending white matter tract located in the posterior portion (back) of the spinal cord, composed mainly of the gracile fasciculus (medially, lower body) and the cuneate fasciculus (laterally, upper body)[3]. It forms the first part of the dorsal column–medial lemniscus pathway (DCML), a sensory pathway in the central nervous system that conveys fine touch, vibration, pressure, two-point discrimination, and conscious proprioception from the skin and joints to the brain. Signals travel through the dorsal root ganglia, enter the spinal cord, ascend the dorsal columns, synapse in the medulla, and ultimately reach the somatosensory cortex. Lesions of this tract result in characteristic sensory deficits but it is not a molecular drug target in itself[1][2][3]. Key point: The "spinal cord dorsal column" is an anatomical structure (a white matter tract), not a molecule, receptor, or protein, and thus does not fit the normal pattern for drug discovery molecular targets[1][3].

Other names
Posterior columnpart of the dorsal column–medial lemniscus pathway (DCML)posterior funiculus
02

Biological functions

Sensory signal transmission, specifically fine touch, vibration, pressure, two-point discrimination, and proprioception from skin and joints
03

Disease associations

Spinal cord injurysensory neuropathiesmultiple sclerosistabes dorsalis (neurosyphilis)other demyelinating or degenerative diseases affecting sensory pathways
04

Safety considerations

Risk of loss of proprioception and fine touch with injury, surgical, or disease-related damage (e.g., leading to ataxia or severe sensory loss)

Beyond the preview

Go deeper on Dorsal column of the spinal cord.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dorsal column of the spinal cord.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call